Clinical Trials Browser

Phase 3 × Interventional × cediranib × Clear all

NCT02446600 2026-03-05

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 3 Active not recruiting

579 enrolled 17 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00795340 2023-08-22

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 3 Completed

306 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03278717 2022-09-27

ICON9

Phase 3 Unknown

Ovarian Neoplasms

NCT00399035 2016-12-28

HORIZON II

Phase 3 Completed

1,254 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT00777153 2016-12-28

REGAL

Phase 3 Completed

423 enrolled 13 charts

Glioblastoma, Neoplasms

NCT00532194 2015-09-23

ICON6

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms